GASTRIC CANCER IS A COMMON MALIGNANCY, AND IS THE LEADING CAUSE OF DEATH AMONG CANCERS

Nguyễn Đức Duy1,, Trần Đại Mạnh1, Nguyễn Duy Thanh1, Phạm Văn Bình1, Nguyễn Xuân Hùng2
1 Vietnam National Cancer Hospital
2 Vietduc University Hospital

Main Article Content

Abstract

Research objective: Early results of distal subtotal gastrectomy, D2 lymphadenectomy, Billroth I anastomosis in the treatment of gastric adenocarcinoma, at the Department of Abdominal Surgery 1, K Hospital. Methodology: Retrospective combined with prospective description of 30 patients with gastric adenocarcinoma, underwent a distal subtotal gastrectomy with D2 lymphadenectomy, Billroth I anastomosis from January 2021 to August 2022 at the Department of Abdominal Surgery 1, K hospital. Result: Through an evaluation study in 30 patients, we found that the age group over 60 years old was the most common, accounting for 53,3%, the incidence in men is higher than in women, accounting for 60%. The average operation time was 143 minutes, the shortest was 120 minutes, the longest was 200 minutes. An average of 22,03 lymph nodes  were removed, lymph node metastasis in N1 and N2 group, accounted for a high rate of 36,7% and 23,3%, respectively.  The majority of the disease is stage III, accounting for 66.7%. The average time of gastric tube removal  after surgery  is 1-2 days, feeding initiation after surgery on day 2nd or 3nd, average hospital stay of 7-8 days. There was 1 case of early postoperative complications (accounting for 0.33%) with pneumonia, patient was treated by medicine, then stabilized and discharged after 14 days. Conclusion: Distal subtotal gastrectomy with D2 lymphadenectomy is safe surgery, feasible, can be performed at any disease stage, low complication rate, shorten surgery time and intraoperative blood loss.

Article Details

References

1. Bùi Trung Nghĩa, THS. Y Học Việt Nam. Kết quả phẫu thuật triệt để điều trị ung thư biểu mô tuyến dạ dày tại Bệnh Viện Hữu Nghị Việt Đức và mối tương quan với một số đặc điểm của giải phẫu bệnh hoc.;2(505).
2. Sun D, Cao M, Li H, He S, Chen W. Cancer burden and trends in China: A review and comparison with Japan and South Korea. Chinese journal of cancer research = Chung-kuo yen cheng yen chiu. 2020;32(2):129-39.
3. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 2017;20(1):1-19.
4. Li JQ, He D, Liang YX. Current status of extended 'D2 plus' lymphadenectomy in advanced gastric cancer. Oncology letters. 2021;21(6):467.
5. He L, Zhao Y. Is Roux-en-Y or Billroth-II reconstruction the preferred choice for gastric cancer patients undergoing distal gastrectomy when Billroth I reconstruction is not applicable? A meta-analysis. Medicine. 2019;98(48):e17093.
6. Kim YN, Aburahmah M, Hyung WJ, Noh SH. A simple method for tension-free Billroth I anastomosis after gastrectomy for gastric cancer. Translational gastroenterology and hepatology. 2017;2:51.
7. Yang K, Zhang WH, Liu K, Chen XZ, Zhou ZG, Hu JK. Comparison of quality of life between Billroth-І and Roux-en-Y anastomosis after distal gastrectomy for gastric cancer: A randomized controlled trial. Scientific reports. 2017;7(1):11245.
8. Nishizaki D, Ganeko R, Hoshino N, Hida K, Obama K, Furukawa TA, et al. Roux-en-Y versus Billroth-I reconstruction after distal gastrectomy for gastric cancer. The Cochrane database of systematic reviews. 2021;9(9):Cd012998.